150.00 rub.
Buy article

Efficacy of primary prevention for atherosclerosis-induced diseases in patients with high cardiovascular risk in Russia and other European countries (Part 1)

Pogosova N. V.1, Oganov R. G.1, Boytsov S. A.1, Ausheva A. K.1, Sokolova O. Yu.1, Kursakov A. A.1, Pozdnyakov Yu. M.1, Gomyranova N. V.1, Karpova A. V.1, Isakova S. S.1, Salbieva A. O.1, Yusubova A. I.1, Lel’chuk I. N.1, Allenov A. M.2, Vinokurov V. G.2, Strelkova S. N.2, Klimova A. O.2, Loshkarev Yu. V.2, Rubanov R. V.2
1 – National Research Center for Preventive Medicine, Petroverigsky Per. 10, Bldg. 3, Moscow 101990, Russia
2 – Municipal Clinic #210, Moscow Department of Health Care, Kashirskoe Shosse 57, Bldg 1, Moscow 115211

Keywords: multi-center study, primary prevention, high cardiovascular risk

DOI: 10.18087/cardio.2411

Relevance. Evaluation of the effectiveness of risk management in persons with high cardiovascular risk is an important element in reducing the death rate of the population from cardiovascular diseases (CVD). Aim. Analysis of the prevalence and level of risk factors control in patients with high CV risk CVD from the Russian centers of the primary care unit of the EUROASPIRE IV study in comparison with the general population of the study. Materials and methods. In this cross-sectional study, 14 European countries, including the Russian Federation, participated. Patients aged 18 to 79 years were included in the study, without clinical manifestations of atherosclerosis, who were prescribed antihypertensive therapy and/or lipid lowering therapy and/or treatment for diabetes between the ages of ≥6 months and <3 years before switching on. The study protocol included analysis of medical records and a visit-interview using a specially designed structured questionnaire on the main aspects of lifestyle (smoking, nutrition, physical activity, psychosocial factors), taking medications and adhering to other recommendations. Anthropometric data, blood pressure, concentration of carbon monoxide (CO) in the exhaled air were also recorded during the interview, and venous blood was taken to determine the levels of lipids, glucose and glycated hemoglobin (HbA1c). All patients without diabetes in the absence of fasting hyperglycaemia ≥11.1 mmol/l conducted an oral glucose tolerance test. Results. In total, 505 patients with known high CV risk were examined in Russian centers and 405 interviews took place (71.6% of women). The prevalence of smoking in the Russian cohort and in the general population of the study was 17.8 and 16.6%, obesity – 56.6 and 43.5%, diabetes – 18.7 and 27.7%, low physical activity – 53.2 and 68.5%, respectively. Support received by patients with smoking quitting was clearly insufficient and rarely included medical therapy. The frequency of reaching the target level of blood pressure on the background of therapy was 68.1 and 42.8%, respectively, and the target level of LDL–C was 26.2 and 32.7%. HbA1c <7% was reported in 64.3% of patients with diabetes in the Russian cohort and 58.5%in the study as a whole. The proportion of patients whose diabetes was detected only during the visit-interview was 26.4% and 21.8%, respectively. Conclusion. The different components of cardiovascular prevention in Russia and in the general population of the study had some differences, while in some areas, in particular in the control of blood pressure, Russian patients with BP achieved even better results than in Europe as a whole. On the contrary, the situation in Russian centers was worse with regard to the prevalence of overweight and obesity in patients with BP, control of blood lipid levels, as well as detection rates not previously diagnosed with diabetes.
  1. Бритов А. Н., Поздняков Ю. М., Волкова Э. Г., Драпкина О. М., Еганян Р. А., Кобалава Ж. Д. и др. Национальные рекомендации по кардиоваскулярной профилактике. Кардиоваскулярная Терапия И Профилактика. 2011;10(6 S2):2–64. [Britov A. N.,
  2. Pozdnyakov Yu. M., Volkova E`. G., Drapkina O. M., Eganyan R. A., Kislyak O. M. et al. Russian Society of Cardiology. Cardiovascular prevention. National Guidelines. Cardiovascular Therapy and Prevention. 2011;10(6 S2):2–64].
  3. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37 (29):2315–81. DOI:10.1093/eurheartj/ehw106.
  4. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Reiner Z et al. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries. Eur J Cardiovasc Prev Rehabil. 2010;17 (5):530–40. DOI:10.1097/HJR.0b013e3283383f30.
  5. Kotseva K, De Bacquer D, De Backer G, Rydén L, Jennings C, Gyberg V et al. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions. Eur J Prev Cardiol. 2016;23 (18):2007–18. DOI:10.1177/2047487316667784.
  6. Баланова Ю. А., Вилков В. Г., Деев А. Д., Капустина А. В., Константинов В. В., Муромцева Г. А. и др. Результаты второго этапа мониторинга эпидемиологической ситуации по артериальной гипертонии в Российской Федерации (2005–2007гг.), проведенного в рамках Федеральной целевой программы «Профилактика и лечение артериальной гипертонии в Российской Федерации». М.; 2008. 224 с [Balanova Yu. A., Vilkov V. G., Deev A. D., Kapustina A. V., Konstantinov V. V., Muromczeva G. A. i dr. Rezul`taty` vtorogo e`tapa monitoringa e`pidemiologicheskoj situaczii po arterial`noj gipertonii v Rossijskoj Federaczii (2005–2007 gg.), provedennogo v ramkax Federal`noj czelevoj programmy` «Profilaktika i lechenie arterial`noj gipertonii v Rossijskoj Federaczii». M.; 2008. 224 s].
  7. Погосова Г. В. Вторичная профилактика артериальной гипертонии и ишемической болезни сердца в реальной клинической практике Российской Федерации. М.: Викас-принт; 2009. 151с [Pogosova G. V. Vtorichnaya profilaktika arterial`noj gipertonii i ishemicheskoj bolezni serdcza v real`noj klinicheskoj praktike Rossijskoj Federaczii. M.: Vikas-print; 2009. 151 s].
  8. Муромцева Г. А., Концевая А. В., Константинов В. В., Артамонова Г. В., Гатагонова Т. М., Дупляков Д. В. и др. Распространенность факторов риска неинфекционных заболеваний в российской популяции в 2012-2013 гг. Результаты исследования ЭССЕ-РФ. Кардиоваскулярная терапия и профилактика. 2014;13 (6):4–11 [Muromczeva G. A., Konczevaya A. V., Konstantinov V. V., Artamonova G. V., Gatagonova T. M., Duplyakov D. V. i dr. Rasprostranennost` faktorov riska neinfekczionny`x zabolevanij v rossijskoj populyaczii v 2012-2013gg. Rezul`taty` issledovaniya E`SSE-RF. Kardiovaskulyarnaya terapiya i profilaktika. 2014;13 (6):4–11].
  9. Погосова Н. В., Оганов Р. Г., Бойцов С. А., Аушева А. К., Соколова О. Ю., Курсаков А. А. и др. Мониторинг вторичной профилактики ишемической болезни сердца в России и Европе: результаты российской части международного многоцентрового исследования EUROASPIRE IV. Кардиология. 2015;55 (12):99–107 [Pogosova N. V., Oganov R. G., Bojczov S. A., Ausheva A. K., Sokolova O. Yu., Kursakov A. A. i dr. Monitoring vtorichnoj profilaktiki ishemicheskoj bolezni serdcza v Rossii i Evrope: rezul`taty` rossijskoj chasti mezhdunarodnogo mnogoczentrovogo issledovaniya EUROASPIRE IV. Kardiologiya. 2015;55 (12):99–107].
  10. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35 (8):1381–95. DOI:10.1249/01. MSS.0000078924.61453. FB.
  11. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67 (6):361–70.
  12. Pogosova N, Kotseva K, De Bacquer D, von Känel R , De Smedt D, Bruthans J et al. Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: Results from the EUROASPIRE IV survey. A registry from the European Society of Cardiology. European Journal of Preventive Cardiology. 2017;24 (13):1371–80. DOI:10.1177/2047487317711334.
  13. Burns EK, Levinson AH. Discontinuation of nicotine replacement therapy among smoking-cessation attempters. American Journal of Preventive Medicine. 2008;34 (3):212–5. DOI:10.1016/j.amepre.2007.11.010.
  14. Fildes A, Charlton J, Rudisill C, Littlejohns P, Prevost AT, Gulliford MC. Probability of an obese person attaining normal body weight: cohort study using electronic health records. Am J Public Health. 2015;105 (9):e54–59. DOI:10.2105/AJPH.2015.302773.
  15. Pietilainen KH, Saarni SE, Kaprio J, Rissanen A. Does dieting make you fat? A twin study. International Journal of Obesity. 2012;36 (3):456–64. DOI:10.1038/ijo.2011.160.
  16. Погосова Н. В., Соколова О. Ю., Юферева Ю. М., Осипова И. В., Рямзина И. Н. Первые результаты анализа российской части европейского регистра по кардиореабилитации (European Cardiac Rehabilitation Database – EuroCaReD) с участием 13 стран. Кардиология. 2015;55 (2):49–56 [Pogosova N. V., Sokolova O. Yu., Yufereva Yu. M., Osipova I. V., Ryamzina I. N. Pervy`e rezul`taty` analiza rossijskoj chasti evropejskogo registra po kardioreabilitaczii (European Cardiac Rehabilitation Database – EuroCaReD) s uchastiem 13 stran. Kardiologiya. 2015;55 (2):49–56].
  17. Чазов Е. И., Оганов Р. Г., Погосова Г. В., Шальнова С. А., Деев А. Д. Клинико-эпидемиолОгическая прОграмма изучения депРессии в карДиологической практИке: у больНых Артериальной гиперТонией и ишемической болезнью сердцА (КООРДИНАТА): результаты многоцентрового исследования. Кардиология. 2007;47 (3):28–37 [Chazov E. I., Oganov R. G., Pogosova G. V., Shal`nova S. A., Deev A. D. Kliniko-e`pidemiolOgicheskaya prOgramma izucheniya depRessii v karDiologicheskoj praktIke: u bol`Ny`x Arterial`noj giperToniej i ishemicheskoj bolezn`yu serdczA (KOORDINATA): rezul`taty` mnogoczentrovogo issledovaniya. Kardiologiya. 2007;47 (3):28–37].
  18. Погосова Г. В., Оганов Р. Г., Колтунов И. Е., Соколова О. Ю., Поздняков Ю. М., Выгодин В. А. и др. Мониторинг вторичной профилактики ишемической болезни сердца в России и странах Европы: результаты международного многоцентрового исследования EUROASPIRE III. Кардиология. 2011;51 (1):34–40 [Pogosova G. V., Oganov R. G., Koltunov I. E., Sokolova O. Yu., Pozdnyakov Yu. M., Vy`godin V. A. i dr. Monitoring vtorichnoj profilaktiki ishemicheskoj bolezni serdcza v Rossii i stranax Evropy`: rezul`taty` mezhdunarodnogo mnogoczentrovogo issledovaniya EUROASPIRE III. Kardiologiya. 2011;51 (1):34–40].
  19. Kotseva K, Wood D, De Bacquer D, De Backer G, Rydén L, Jennings C et al. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016;23 (6):636–48. DOI:10.1177/2047487315569401.
Pogosova N. V., Oganov R. G., Boytsov S. A., Ausheva A. K., Sokolova O. Yu., Kursakov A. A. et al. Efficacy of primary prevention for atherosclerosis-induced diseases in patients with high cardiovascular risk in Russia and other European countries (Part 1). Kardiologiia. 2017;57(S1):333–344

To access this material please log in or register

Register Authorize
Ru En